Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
171 hedge funds and large institutions have $772M invested in Avid Bioservices, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 61 increasing their positions, 48 reducing their positions, and 24 closing their positions.
66% more capital invested
Capital invested by funds: $465M → $772M (+$307M)
27% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 48
0% more funds holding
Funds holding: 171 → 171 (0)
0% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 24
10% less call options, than puts
Call options by funds: $1.96M | Put options by funds: $2.18M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$27.8M |
| 2 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$14.5M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$11.5M |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$10.5M |
| 5 |
PD
Point72 (DIFC)
Dubai,
United Arab Emirates
|
+$9.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1WCM
12 West Capital Management
New York
|
-$26M |
| 2 |
CCM
Coliseum Capital Management
Rowayton,
Connecticut
|
-$12.5M |
| 3 |
Millennium Management
New York
|
-$9.14M |
| 4 |
ACA
AYAL Capital Advisors
Toronto,
Ontario, Canada
|
-$5.49M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$5.19M |
CDMO Hedge Fund Activity: Q3 2024 in Review
171 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q3 2024, worth a combined $772M — up 66% from $465M a quarter earlier.
Fund positioning in CDMO was balanced in Q3 2024: 24 funds opened new positions, 24 closed out, 61 added to existing stakes and 48 trimmed.
The largest buyer was First Light Asset Management, opening a new position worth an estimated $27.8M. The largest seller was 12 West Capital Management, exiting entirely with an estimated $26M sold.
- 171 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $772M of Avid Bioservices, Inc. Common Stock stock for Q3 2024, up 66% quarter-over-quarter.
- 24 funds opened new Avid Bioservices, Inc. Common Stock positions in Q3 2024 and 24 closed out, a net change of 0 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q3 2024 was First Light Asset Management, an estimated $27.8M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q3 2024 was 12 West Capital Management, an estimated $26M sold.
Based on aggregated 13F filings for Q3 2024.